Synopsis Of Diabetes Mellitus by Ogedengbe, OS
 
 101  
 
SYNOPSIS OF DIABETES MELLITUS 
 
*O. S. Ogedengbe 
 
*Department of Medicine, University of Benin Teaching Hospital, Benin City, Nigeria. 
 
Correspondence: 
Dr O. S. Ogedengbe   
Department of Medicine 
University of Benin Teaching Hospital 
P.M.B. 1111 Benin City 




Diabetes mellitus is a metabolic 
disorder that is presently troubling the 
world, posing a great socio-economic 
burden to very nation.  An overview on 
the definition, diagnosis, potential 
dangers and current prevention and 
treatment options available in putting a 
check to this disease will go a long 
way in helping physicians, diabetic 
patients and even diabetic relatives 
(whom themselves have an increased 
risk of developing the disease) in 
controlling the alarming increase in the 
prevalence  of diabetes mellitus being 
experienced today.  
 
DEFINITION 
The term diabetes mellitus describes a 
chronic metabolic disorder of multiple 
aetiology characterized by 
hyperglycaemia with disturbances of 
carbohydrate, fat and protein 
metabolism resulting from a relative or 
an absolute lack in insulin. 
 
EPIDEMIOLOGY 
Dramatically, over the past two 
decades the worldwide prevalence of 
DM has risen from an estimated 30 
million cases in 1985 to 177 million in 
2000. Based on current trends, over 
360 million individuals will have 
diabetes by the year 2030. The 
prevalence of both type 1 and type 2 
DM is increasing worldwide, the 
prevalence of type 2 DM is rising much 
more rapidly because of increasing 
obesity and reduced activity levels as 
countries become more industrialized. 
With respect to sex distribution, the 
prevalence is similar in men and 
women throughout most age ranges 
(10.5% and 8.8% in individuals >20 
years respectively) but is slightly 
greater in men >60 years. 
 Worldwide estimates project that in 
2030 the greatest number of 
individuals with diabetes will be 45–64 
years of age. 
There exist a considerable geographic 
variation in the incidence of DM and 
this variability is likely due to genetic, 
behavioral, and environmental factors. 
Scandinavian countries have the 
highest incidence of type 1 DM (e.g., in 
Finland, the incidence is 35/100,000 
per year) while the Pacific Rim has a 
much lower rate (in Japan and China, 
the incidence is 1–3/100,000 per year) 
of type 1 DM; Northern Europe and the 
United States have an intermediate 
rate (8–17/100,000 per year). In 2005, 
the CDC estimated that the prevalence 
of DM in the United States (age > 20 
years) was; African Americans-13.3%, 
Latinos-9.5%, Native Americans 
(American Indians and Alaska natives) 
-15.1%, and non-Hispanic whites-
8.7%. 
Both males and females are affected. 
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Sex, age and ethnic background are 
important factors in determining risk of 
developing type 2 DM.  
 
AETIOLOGY / RISK FACTORS 
The causes/ risk factors for diabetes 
mellitus depend on the aetiological 
classification being looked at. 
AETIOLOGICAL CLASSIFICATION 
OF DISORDERS OF GLYCAEMIA* 
--Type 1 (beta-cell destruction, usually 
leading to absolute insulin deficiency) 
A) Autoimmune 
B) Idiopathic 
--Type 2 (may range from 
predominantly insulin resistance with 
relative insulin deficiency to a 
predominantly secretory defect with or 
without insulin resistance) 
--Other specific types  
Genetic defects of beta-cell function 
Genetic defects in insulin action 
Diseases of the exocrine pancreas 
Endocrinopathies 
Drug- or chemical-induced 
Infections 
Uncommon forms of immune-mediated 
diabetes 




*As additional subtypes are 
discovered it is anticipated that they 
will be reclassified within their own 
specific category. 
**Includes the former categories of 
gestational impaired glucose 
tolerance and gestational diabetes. 
CULLED FROM: Definition, Diagnosis 
and Classification of Diabetes Mellitus 
and its Complications Report of a 
WHO Consultation Part 1: Diagnosis 
and Classification of Diabetes Mellitus 
World Health Organization Department 
of Non-communicable Disease 
Surveillance Geneva. 
CLINICAL FEATURES  
This is a clinical condition that is 
described as a state of starvation in 
the midst of plenty. Some others 
describe it as a disease of plenty;  
• Plenty urine 
• Plenty sugar 
• Plenty drinking 
• Plenty eating  
• Plenty problems (multiple 
complications) 
The things that are not plenty in 
these conditions are: 
• Insulin in type 1 patients 
(hyperinsulinaemia may 
occur in Type 2) 
• Weight loss especially in 
type 1 (in type 2, 
depending on the level of 
control) 
• Money for investigations 
and treatment (poverty). 
 
TYPE 1 DIABETES MELLITUS 
Although typically diagnosed in 
patients before age 30, it can present 
at any age due to variability in the rate 
of beta-cell destruction.  
TYPE 2 DIABETES MELLITUS 
Type 2 DM is known to account for 90-
95% of cases of DM globally.   In 
Africa, DM currently affects about 10 
million people in the 20-79 year age 
group with the figure estimated to 
increase to 18 million by the year 
2025.  The prevalence of DM in this 
same age group is estimated to rise 
from 3.5% to 4.5%.  A study by 
Nyenwe et al in Port- Harcourt, Nigeria 
in 2003 reported a  crude prevalence 
rate of 6.8% for type 2 DM and a 
standardized prevalence  rate of 7.9%. 
The National standardized prevalence 
rate of DM in Nigeria is 2.2% and the 
crude prevalence rate is 7.4% in 
individuals aged 45 years and above 
living in urban areas.    
DIABETES IN PREGNANCY 
Gestational diabetes is carbohydrate 
intolerance resulting in hyperglycaemia 
of variable severity with onset or first 
recognition during pregnancy. This 
does not in any way exclude the 
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possibility that the glucose intolerance 
may antedate pregnancy but has been 
previously unrecognized. The 
definition applies irrespective of 
whether or not insulin is used for 
treatment or the condition persists 
after pregnancy.  
The risk factors for gestational 
diabetes mellitus are Obesity, Ethnicity 
(South Asian, black, Hispanic, Native 
American), Family history of type 2 
diabetes, previous glucose 
abnormalities in pregnancy   and 
previous macrosomia. 
 It is important to note that women who 
become pregnant and who are known 
to have diabetes mellitus which 
antedates pregnancy do not have 
gestational diabetes but have 
“diabetes mellitus and pregnancy” and 
should be treated accordingly before, 
during, and after the pregnancy.  
In making a diagnosis of gestational 
diabetes mellitus a standard OGTT 
should be performed after overnight 
fasting (8–14 hours) by giving 75 g 
anhydrous glucose in 250–300 ml 
water. Plasma glucose is measured 
fasting and after 2 hours. Pregnant   
women who meet WHO criteria for 
diabetes mellitus or IGT are classified 
as having Gestational Diabetes 
Mellitus. After the pregnancy ends, the 
woman should be re–classified as 
having either diabetes mellitus, or IGT, 
or normal glucose tolerance based on 
the results of a 75 g OGTT six weeks 
or more after delivery. It is important to 
note that such women, regardless of 
the 6–week post–pregnancy result, are 
at increased risk of subsequently 
developing diabetes.  
 
 OTHER SPECIFIC TYPES 
Other etiologies for diabetes mellitus 
include specific genetic defects in 
insulin secretion or action, metabolic 
abnormalities that impair insulin 
secretion, mitochondrial abnormalities, 
and a host of conditions that impair 
glucose tolerance. Mutations in the 
insulin receptor cause a group of rare 
disorders characterized by severe 
insulin resistance. 
Maturity onset diabetes of the young 
(MODY) is a subtype of DM 
characterized by autosomal dominant 
inheritance, early onset of 
hyperglycemia (usually <25 years), 
and impairment in insulin secretion.  
Also, diabetes can result from 
pancreatic exocrine disease when the 
majority of pancreatic islets are 
destroyed. Hormones that antagonize 
insulin action can also lead to diabetes 
mellitus. Thus, DM is often a feature of 
endocrinopathies such as acromegaly 
and Cushing's disease. Viral infections 
have been implicated in pancreatic 
islet destruction but are an extremely 
rare cause of DM.  
 
Malnutrition-related DM 
This condition also known as tropical 
diabetes tends to occur in 
malnourished children. It is commoner 
in the tropics where malnutrition and 
cassava consumption have been 
implicated as its aetiology. Individuals 
with this type of diabetes tend to have 
insulin resistance and often require 
high doses of insulin for control. It is 
associated with pancreatic fibrosis and 
calcification (fibrocalculous 
pancreatopathy). Patients with this 
type of DM may give a history of 
passing poorly digested food particles 
in their stools. They may also give a 
history of severe abdominal pain in the 
past.  
It is important to note that a form of 
acute onset of type 1 diabetes mellitus, 
termed fulminant diabetes, has been 
noted in Japan and may be related to 
viral infection of islets. 
 
INVESTIGATIONS 
MAKING A DIAGNOSIS 
FBS-- ≥ 126mg/dL or 7mmol/L 
RBS-- ≥ 200mg/dL or 11.1mmol/L 
Vol. 11 No. 1 December, 2009      Synopsis of diabetes mellitus 
 104  
 
OGTT*-- ≥ 126mg/dL and 2 hours 
postprandial of ≥ 210mg/dL 
*The oral glucose tolerance test 
(OGTT) is principally used for 
diagnosis when blood glucose levels 




FASTING SERUM LIPID PROFILE- 
may have hyperlipidaemia or 
dyslipidaemia  
AUTOANTIBODY TESTING- type 1 
DM individuals may have antibodies to 
islet cells, glutamic acid decarboxylase 
(GAD) and even insulin  
 
LIVER FUNCTION TEST + SERUM 
PROTEINS – fatty liver can occur in 
diabetics and this may progress to 
chronic hepatitis with abnormal liver 
functions.  Diabetes can be associated 
with liver conditions in disease states 
like; haemochromatosis, autoimmune 
hepatitis and hepatitis C viral infection. 
In such conditions patients with 
diabetes may come down with 
jaundice and other stigmata of liver 
disease.  Those with autoimmune type 
1 DM may have other autoimmune 
conditions like autoimmune haemolytic 
anaemia with jaundice as a feature.  
 
INSULIN RESISTANCE – using the 
insulin clamp method or homeostasis 
model assessment method (HOMA) 
NB- a finding of acanthosis nigricans is 
suggestive of insulin resistance. It may 
also be a skin manifestation of an 
internal malignancy. It can be found 
around the neck, axillar, groin or anal 
region. 
 
ECG- may show evidence of 
ischaemic heart disease. It is important 
to remember that they can suffer a 
silent myocardial infarction (painless 
MI) 
 
CHEST X-RAY – may show 
cardiomegaly, hypertensive heart 
changes for those that are 
hypertensive and may show evidence 
of chest infection as they are prone to 
having infections. Lazy 
leukocyte/defective opsonization being 
responsible for the increased risk of 
infection. The hyperglycaemia is also 
known to the encourage growth of 
microbes.  
 
URINALYSIS- may show protein, 
glucose and/ or ketones in urine 
depending on how the patient 
presents. 
  
URINE M/C/S- may show evidence of 
infection 
 
WOUND SWAB FOR M/C/S – may 
also show evidence of infection 
DOPPLER SCAN- may be indicated in 
those with peripheral vascular disease. 
COMPLICATIONS 
Can be grouped into the ACUTE and 
the CHRONIC complications. 
ACUTE COMPLICATIONS 
Diabetic ketoacidosis 




Acute circulatory failure 
 
CHRONIC COMPLICATIONS 
a) Microvascular complications 
I. Diabetic retinopathy 
II. Diabetic nephropathy 
III. Peripheral neuropathy 
b) Macrovascular complications 
I. Peripheral vascular disease 
II. Ischaemic heart disease 
III. Stroke 
c) Others 
I. Fetal macrosomia 
II. Intrauterine growth resriction 
III. Intrauterine fetal death 
IV. Cataracts 
V. Diabetic dermopathy 
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VI. Bullae formation 
VII. Foot ulcers 
VIII. Recurrent boils 
IX. Generalised pruritus 
X. Gas gangrene 
XI. Dupuytren’s contracture 
 
These are just some of the 
complications that can occur in 
diabetics. 
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INDICATIONS FOR INSULIN 
THERAPY 
• TYPE 1 Diabetes mellitus 
• Gestational Diabetes mellitus/ 
Diabetes in pregnancy 
• Oral glucose lowering agents 
failure 
• Treatment of Diabetic 
emergencies like DKA and HHS 
• For patients going for surgery 
and even in post –op state 
• Myocardial infarction/stroke/ 
diabetic foot ulcer 
• Insulin can also be used in 
treating hyperkalaemia. 
 
COMPLICATIONS OF INSULIN 
THERAPY 
• Hypoglycaemia 
• Weight gain 
• Lipodystrophy/Lipohypertrophy 
• Infections at injection sites 
• Thrombophlebitis 
• Insulin oedema 
• Hypokalaemia
 
2. ORAL MEDICATIONS (SEE TABLE II) 

















Metformin Weight loss Lactic acidosis, 
diarrhea, nausea 
Serum creatinine 

























Sitagliptin Does not cause 
hypoglycaemia 
  Reduce dose with 
renal disease 


















Insulin secretion Repaglinide 
Nateglinide 


















increase risk of MI 
Congestive heart 
failure, liver disease 
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B. SURGERY – may be indicated in patients with Diabetic foot with gangrene. Islet 
cell transplantation alongside renal transplantation has been done in those with DM 
nephropathy. 
 
C. NON DRUG TREATMENT 
Diet, weight reduction and exercise 
 
D. EXPERIMENTAL OPTIONS 
 
CONCLUSION 
Diabetes mellitus is a chronic clinical 
condition requiring a multidisciplinary 
care. Presently, it is a condition 
demanding an urgent action plan to 
curb its alarming prevalence. It is cost 
effective to prevent than to treat this 
disorder.   
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